BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2011
View Archived Issues
Phase II data reveal antitumor activity of SCH-727965 in breast cancer but not in NSCLC
Read More
Pfizer and UCSD describe PF-04449913, an oncolytic agent now in phase I development
Read More
AstraZeneca reports potent antidepressant/anxiolytic effects for AZD-2327 in vivo
Read More
GenKyoTex patents novel NADPH oxidase inhibitors
Read More
Cancer vaccines with tumor antigen H/K-HELP induce Th1 immune responses in patients
Read More
Small-molecule erythropoietin mimetic STS-E15 displays neuroprotective activity in vitro
Read More
Anavex begins dosing in phase I trial of ANAVEX 2-73 for Alzheimer's disease
Read More
Stanford University and SanBio begin phase I/II trial of cell therapy SB6-23 for stroke disability
Read More
New PRL-R-directed antibody LFA-102 shows promise as an oncolytic in preclinical tests
Read More
Qilu Pharma presents new receptor tyrosine-protein kinase inhibitors
Read More
Takeda claims novel ionotropic glutamate receptor agonists
Read More
New HSP 90 inhibitors synthesized by Aegera scientists
Read More
Chinese researchers prepare novel antibacterial and antifungal agents
Read More
Boston Scientific announces U.S. approval and launch of Ion paclitaxel-eluting stent
Read More
AIC-246 receives European orphan drug status for prevention of HCMV disease
Read More
Kyowa Hakko Kirin files NDA in Japan for KW-0761 in adult T-cell leukemia-lymphoma
Read More
Merck & Co. and Sanofi Pasteur begin phase III program for pediatric hexavalent combination vaccine
Read More
Mochida receives marketing approval in Japan for antidepressant Lexapro 10 mg
Read More
Tissue Genesis begins phase I/II trial of ASC-coated vascular grafts in peripheral vascular disease
Read More
European Commission approves Hizentra for primary and secondary immunodeficiencies
Read More
Kuros' phase IIb trial of KUR-113 in open tibial shaft fractures meets primary endpoint
Read More
Thymoglobuline is approved in Japan for treatment of acute renal transplant rejection
Read More
Japanese approval for Tramcet tablets for noncancer pain and pain after tooth extraction
Read More
Idera Pharma delays phase II study of IMO-2125 pending further toxicology results
Read More
Noscira begins phase IIb European trial of Nypta in Alzheimer's disease
Read More
Dosing begins in phase IIb study of TB-402 to prevent venous thromboembolism
Read More
